Volume 14, Number 7—July 2008
Letter
Pertussis Surveillance in Private Pediatric Practices, France, 2002–2006
Table
Characteristic | Vaccinated 4× with Pw vaccine (N = 70) |
Unvaccinated (N = 69) |
||||
---|---|---|---|---|---|---|
Confirmed case-patients (n = 22) | Nonconfirmed case-patients (n = 48) | Confirmed case-patients (n = 25) | Nonconfirmed case-patients (n = 44) | |||
Diagnostic method | ||||||
Culture | 0† | 3* | ||||
PCR | 7† | 17* | ||||
Serology | 13 | 3 | ||||
Epidemiology |
2 |
2 |
||||
Age, y |
9.9 ± 2.1† |
7.8 ± 3.4 |
2.3 ± 3.9† |
0.8 ± 2.3 |
||
p value for age |
0.008 |
0.0046 |
||||
Source of contamination |
||||||
Adults | 5 | 7 | ||||
Adolescents | 4 | 5 | ||||
Infants | 1 (unvaccinated) | 0 |
*p = 0.0009 for PCR and culture for case-patients receiving 4 doses of Pw vaccine versus unvaccinated confirmed case-patients.
†p<0.0001 by age for case-patients receiving 4 doses of Pw vaccine versus unvaccinated confirmed case-patients.
Page created: July 12, 2010
Page updated: July 12, 2010
Page reviewed: July 12, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.